Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

June 07, 2024 00:22:24
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial
Critical Care Perspectives in Emergency Medicine
Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Jun 07 2024 | 00:22:24

/

Show Notes

Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at risk of a resistant gram-negative organism.  The two most common antipseudomonal antibiotics prescribed in this setting are cefepime and piperacillin-tazobactam.  In recent years, observational studies have reported an association with cefepime and neurotoxicity, whereas piperacillin-tazobactam has been associated with AKI especially when given with vancomycin.  In this podcast, we discuss the recently published ACORN Trial, a randomized trial that evaluated cefepime and piperacillin-tazobactam for adult patients with suspected infection.

Other Episodes

Episode

January 27, 2017 00:24:56
Episode Cover

The Complicated Alcohol Withdrawal Patient

Bryan Hayes is back!  In this podcast, we discuss pitfalls in the use of benzodiazpines along with current evidence on adjunctive treatments including propofol,...

Listen

Episode

July 09, 2024 00:26:28
Episode Cover

Should We Use NIPPV for Preoxygenation for All Intubations?

Over 1 million critically ill patients are intubated each year in the US.  Hypoxemia occurs in up to 20% of patients and can lead...

Listen

Episode

September 24, 2024 00:29:51
Episode Cover

Continuous or Intermittent B-Lactam Infusions for Sepsis?

Timely administration of broad-spectrum antibiotics is a critical pillar in the resuscitation of patients with sepsis.  B-lactam antibiotics are an important class of antibiotics...

Listen